In the Spotlight

A mitral valve annuloplasty ring with innovative chordal guiding system standardizes artificial chord replacement Milan, Italy, October 22, 2014 – Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced ...+
European and North American cohorts study demonstrates safety and excellent clinical and hemodynamic performance of Sorin’s stentless aortic valve Milan, Italy, October 15, 2014 – Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment ...+
Latest results on the largest patient cohorts implanted with Perceval sutureless valves demonstrate durability, excellent hemodynamic performance and low complication rates Milan, Italy, October 13, 2014 -- Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in ...+
Solo Smart, the first aortic tissue valve with a removable stent, was successfully implanted in the first US patient. Milan, Italy, October 7, 2014 –Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, ...+
New stented aortic bioprosthesis with outstanding ease of use and performance successfully implanted in Austria Milan, Italy, September 2nd, 2014 – Sorin Group, (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today ...+

News

Events